Your search for major depressive disorder returned 13 results

Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.

Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.

The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.

Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?

Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.